Reyataz

Antiretroviral Therapy, HIV, Obesity
Treatment
20 Active Studies for Reyataz

What is Reyataz

AtazanavirThe Generic name of this drug
Treatment SummaryAtazanavir (formerly known as BMS-232632) is a medication used to treat HIV infection. It is part of a class of drugs called protease inhibitors. Atazanavir is different from other protease inhibitors as it only needs to be taken once a day and has less of an effect on the patient's cholesterol levels. It is always used with other HIV medications. The FDA approved atazanavir in 2003.
Reyatazis the brand name
image of different drug pills on a surface
Reyataz Overview & Background
Brand Name
Generic Name
First FDA Approval
How many FDA approvals?
Reyataz
Atazanavir
2003
63

Effectiveness

How Reyataz Affects PatientsAtazanavir is a drug that works against Human Immunodeficiency Virus Type 1 (HIV-1). It blocks an enzyme called HIV-1 protease, which is necessary for the virus to form and spread. Atazanavir should be used with other anti-HIV drugs in order to be effective. It is similar but different from other protease inhibitors and other antiretroviral drugs currently available.
How Reyataz works in the bodyAtazanavir targets the HIV-1 virus and stops it from forming mature virions. It does this by blocking the active site of the HIV-1 protease, which is responsible for the processing of the virus' proteins. Atazanavir does not work against the HIV-2 virus.

When to interrupt dosage

The proposed dosage of Reyataz is predicated upon the determined condition, including weight of at least 35 kg, Antiretroviral Therapy and HIV (Human Immunodeficiency Virus). The measure of dosage is contingent upon the form of administration (e.g. Tablet, film coated or Oral) featured in the table below.
Condition
Dosage
Administration
Antiretroviral Therapy
150.0 mg, , 200.0 mg, 300.0 mg, 100.0 mg, 50.0 mg
, Oral, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Capsule, Capsule - Oral, Tablet, Tablet - Oral, Powder, Powder - Oral, Tablet, film coated - Oral, Tablet, film coated
HIV
150.0 mg, , 200.0 mg, 300.0 mg, 100.0 mg, 50.0 mg
, Oral, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Capsule, Capsule - Oral, Tablet, Tablet - Oral, Powder, Powder - Oral, Tablet, film coated - Oral, Tablet, film coated
Obesity
150.0 mg, , 200.0 mg, 300.0 mg, 100.0 mg, 50.0 mg
, Oral, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Capsule, Capsule - Oral, Tablet, Tablet - Oral, Powder, Powder - Oral, Tablet, film coated - Oral, Tablet, film coated

Warnings

Reyataz has nineteen contraindications, and its use should be avoided where any of the conditions in the following table are present.Reyataz Contraindications
Condition
Risk Level
Notes
Pulse Frequency
Do Not Combine
Pulse Frequency
Do Not Combine
Pulse Frequency
Do Not Combine
Pulse Frequency
Do Not Combine
Pulse Frequency
Do Not Combine
Pulse Frequency
Do Not Combine
Pulse Frequency
Do Not Combine
Pulse Frequency
Do Not Combine
Pulse Frequency
Do Not Combine
Pulse Frequency
Do Not Combine
Pulse Frequency
Do Not Combine
Pulse Frequency
Do Not Combine
Pulse Frequency
Do Not Combine
Pulse Frequency
Do Not Combine
Pulse Frequency
Do Not Combine
Pulse Frequency
Do Not Combine
Pulse Frequency
Do Not Combine
Pulse Frequency
Do Not Combine
Pulse Frequency
Do Not Combine
There are 20 known major drug interactions with Reyataz.
Common Reyataz Drug Interactions
Drug Name
Risk Level
Description
(R)-warfarin
Major
The metabolism of (R)-warfarin can be decreased when combined with Atazanavir.
(S)-Warfarin
Major
The metabolism of (S)-Warfarin can be decreased when combined with Atazanavir.
1,2-Benzodiazepine
Major
The metabolism of 1,2-Benzodiazepine can be decreased when combined with Atazanavir.
3,5-diiodothyropropionic acid
Major
The metabolism of 3,5-diiodothyropropionic acid can be decreased when combined with Atazanavir.
5-androstenedione
Major
The metabolism of 5-androstenedione can be decreased when combined with Atazanavir.
image of a doctor in a lab doing drug, clinical research

Reyataz Novel Uses: Which Conditions Have a Clinical Trial Featuring Reyataz?

44 active trials are in progress to investigate the utility of Reyataz in treating HIV (Human Immunodeficiency Virus) and Antiretroviral Therapy in individuals of weight at least 35 kg.
Condition
Clinical Trials
Trial Phases
Antiretroviral Therapy
1 Actively Recruiting
Phase 2
Obesity
0 Actively Recruiting
HIV
38 Actively Recruiting
Phase 2, Phase 3, Early Phase 1, Not Applicable, Phase 1, Phase 4

Reyataz Reviews: What are patients saying about Reyataz?

5Patient Review
9/19/2009
Reyataz for HIV
I've been on this medication for five years now. When I first started, the side effects were really bad (vomiting and diarrhea for about three weeks). But I haven't had any problems since then.
5Patient Review
4/2/2013
Reyataz for HIV
I've been taking Reyataz and Epzicom for four years now with excellent results. I take it every night with dinner and have had no negative side effects that I can tell. My T-cells have increased from 480 to 1000 in that time, and other measures like my lipids have stayed good too.
5Patient Review
3/8/2008
Reyataz for HIV
I didn't experience any negative side effects from this treatment, except for some unwanted weight gain in my midsection.
5Patient Review
5/15/2009
Reyataz for HIV
I've been using this medication for a while now and I haven't experienced any negative side effects. I'm very pleased with it overall.
5Patient Review
7/30/2008
Reyataz for HIV
I've been on Reyataz for almost three years now, and it's by far the best protease inhibitor I've ever taken. I highly recommend it to anyone who is looking for a new lease on life.
View All Reviews
image of drug pills surrounding a glass of water symbolizing drug consumption

Patient Q&A Section about reyataz

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is there a generic for Reyataz?

"Teva Pharmaceuticals has announced the launch of a generic version of the drug Reyataz in the United States. The drug is indicated for use in combination with other antiretroviral agents, and acts as a protease inhibitor for the treatment of HIV-1 infection in patients six years of age and older weighing at least 15 kg."

Answered by AI

What are the side effects of Reyataz?

"If you experience any of the following symptoms, you may be suffering from the flu: nausea, headache, stomach-area pain, vomiting, trouble sleeping, numbness, tingling, or burning of hands or feet, dizziness, muscle pain."

Answered by AI

What is Reyataz used for?

"This drug is used in conjunction with other HIV medications to help control the spread of the virus. By decreasing the amount of HIV in the body, it allows the immune system to function more effectively, lowering the chances of developing complications such as new infections or cancer, and improving the patient's quality of life."

Answered by AI

Who manufactures Reyataz?

"Teva Pharmaceuticals has announced that it will be the exclusive manufacturer of a generic version of the brand-name antiretroviral (ARV) medication Reyataz (atazanavir). Reyataz is approved for use in combination with two or more other ARVs to treat HIV."

Answered by AI

Clinical Trials for Reyataz

Have you considered Reyataz clinical trials? We made a collection of clinical trials featuring Reyataz, we think they might fit your search criteria.
Have you considered Reyataz clinical trials? We made a collection of clinical trials featuring Reyataz, we think they might fit your search criteria.
Have you considered Reyataz clinical trials? We made a collection of clinical trials featuring Reyataz, we think they might fit your search criteria.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top